Standout Papers

Global prevalence of SARS-CoV-2 3CL protease mutations associated with nirmatrelvir or ensitrelvir resistance 2023 2026 202462
  1. Global prevalence of SARS-CoV-2 3CL protease mutations associated with nirmatrelvir or ensitrelvir resistance (2023)
    Jonathan Daniel Ip, Allen Wing‐Ho Chu et al. EBioMedicine

Immediate Impact

2 from Science/Nature 53 standout
Sub-graph 1 of 21

Citing Papers

Enhanced Deep Image Prior for Unsupervised Hyperspectral Image Super-Resolution
2025 Standout
Design of a SARS-CoV-2 papain-like protease inhibitor with antiviral efficacy in a mouse model
2024 StandoutScience
2 intermediate papers

Works of Syed Muhammad Abdullah being referenced

Global prevalence of SARS-CoV-2 3CL protease mutations associated with nirmatrelvir or ensitrelvir resistance
2023 Standout
A Multivariate Empirical Mode DecompositionBased Approach to Pansharpening
2015

Author Peers

Author Last Decade Papers Cites
Syed Muhammad Abdullah 128 53 24 59 13 357
Henry Laniado 93 17 4 20 22 321
Heng Weng 17 67 29 6 31 366
Bing Chen 48 69 117 12 23 390
Garima Verma 9 14 55 11 53 372
Xi Li 7 31 158 67 25 400
Mohammad Reza Faraji 49 10 131 8 19 325
Anam Habib 24 5 12 5 16 332
José Luis Álvarez Macías 15 5 9 12 18 350
Unnikrishnan Payyappallimana 18 45 4 9 30 388
John Hicks 6 99 24 7 18 382

All Works

Loading papers...

Rankless by CCL
2026